Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Total Liabilities ₹880 Cr₹793 Cr₹739 Cr₹157 Cr₹119 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹880 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr
Mar2012₹119 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr
32.15
Mar2012 ₹119 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹302.1 Cr -5.6% 1.9% -16.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,295.0 Cr -0.8% 6.7% 26.7% Stock Analytics
KAVERI SEED COMPANY ₹7,349.6 Cr -8.1% 12.8% 87.4% Stock Analytics
VENKYS (INDIA) ₹2,392.0 Cr -1.6% 1% -2.2% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,429.6 Cr -12.8% 8.2% -36.7% Stock Analytics
INDO US BIOTECH ₹340.9 Cr -1.9% 8.4% -29.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-5.6%

1.9%

-16.4%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses